NCT06344832Not yet recruiting
SSTR PET/CT for Preoperative N Stage Evaluation in GEP-NETs
Somatostatin Receptor Antagonist PET/CT for Pre-operative N Stage Evaluation in Patients With Gastro-entero-pancreatic Neuroendocrine Tumors
Source: ClinicalTrials.gov · Last updated 3 Apr 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The research aims to prospectively include patients with GEP-NENs, undergo preoperative imaging assessment (including PET/CT and contrast-enhanced CT), and accurately delineate lymph node regions. Through postoperative pathological reports, the diagnostic performance of lymph node metastasis (LNM) in GEP-NENs is evaluated. Factors influencing the diagnostic accuracy of SSTR-PET/CT and contrast-enhanced CT are also investigated.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 28 Mar 2024
- Start date
- 1 Apr 2024
- Primary completion date
- 1 Mar 2028
- Lead sponsor
- Peking Union Medical College Hospital
- Diseases
- Neuroendocrine tumours, Pancreatic cancer
- NCT number
- NCT06344832
What you commit to
- Study type: Observational
- Planned participants: 40
- From 1 Apr 2024 to the primary completion date, 1 Mar 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of concomitant malignancies;
Other
- Cases diagnosed pathologically as non-GEP-NEN.
Who the study is looking for
- Age \> 18 years old;
- Patients diagnosed with GEP-NEN by surgical pathology;
- Complete medical records including basic information and treatment process;
- Patients who have undergone preoperative contrast-enhanced CT and 68Ga-SSTR-PET/CT, and have consented to the 68Ga-SSTR-PET/CT project in the Nuclear Medicine Department.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.